With Antibiotic Cement Versus Without Antibiotic Cement in the Treatment of Tibial Osteomyelitis After Radical Debridement: A Randomized Controlled Trial

Background: In most of the cases, antibiotic cement is recommended to fill the dead space after debridement of osteomyelitis. As to local Cierny-Mader Type IV tibial osteomyelitis, radical debridement of the infected bone can be achieved, after that, is it still necessary to apply antibiotic cement to the dead space? This study was aimed to answer the question.Methods: From January 2010 to January 2015, 64 patients with local Cierny-Mader Type IV tibial osteomyelitis were included and randomly divided into two groups. Patients in the cement group were treated with antibiotic-impregnated bone cement after radical debridement of the infected bone (cement group), while the other patients in the without cement group were not applied any cement after the same debridement (without cement group). Both groups were operated by the same surgical team and applied Ilizarov bone transport to fill the bone defect.Result: All patients in both groups achieved successful healing with bone union at both corticotomy and tibial docking sites. At the end of follow-up,there was one case of infection recurrence in each groups. There were no differences in demographics and clinical variables between the two groups. There was also no difference either in terms of bone results or functional results between the two groups (c 2=0.006 for bone results and c 2=1.339 for functional results). But there was significant difference in terms of total hospitalization expenses between the two groups (P<0.001, the cement group was much higher than the without cement group).Conclusion: When radical debridement is achieved in dealing with local Cierny-Mader Type IV tibial osteomyelitis, it is no need to apply antibiotics cement in the dead space, but it needs more cases to increase the convincingness.Trial registration: ChiCTR-TNRC-10002837,retrospectively registered.

[1]  J. Aurégan,et al.  Bioactive glass for long bone infection: a systematic review. , 2015, Injury.

[2]  M. McNally,et al.  The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. , 2014, The bone & joint journal.

[3]  E. Sheehan,et al.  Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis , 2013, Irish Journal of Medical Science.

[4]  D. Peng,et al.  Management of combined bone defect and limb-length discrepancy after tibial chronic osteomyelitis. , 2011, Orthopedics.

[5]  A. Masquelet,et al.  The concept of induced membrane for reconstruction of long bone defects. , 2010, The Orthopedic clinics of North America.

[6]  D. Biau,et al.  Case Report: Reconstruction of a 16-cm Diaphyseal Defect after Ewing’s Resection in a Child , 2009, Clinical orthopaedics and related research.

[7]  W. Pederson,et al.  Long bone reconstruction with vascularized bone grafts. , 2007, The Orthopedic clinics of North America.

[8]  Paul T. Freudigman,et al.  Simultaneous Treatment of Tibial Bone and Soft-tissue Defects With the Ilizarov Method , 2006, Journal of orthopaedic trauma.

[9]  A. Masquelet,et al.  Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction , 2003, Langenbeck's Archives of Surgery.

[10]  J. Mader,et al.  A Clinical Staging System for Adult Osteomyelitis , 2003, Clinical orthopaedics and related research.

[11]  M. Kumar,et al.  Use of Antibiotic-Loaded Polymethyl Methacrylate Beads in the Management of Musculoskeletal Sepsis — A Retrospective Study , 2003, Journal of orthopaedic surgery.

[12]  M. McKee,et al.  The Use of an Antibiotic-Impregnated, Osteoconductive, Bioabsorbable Bone Substitute in the Treatment of Infected Long Bone Defects: Early Results of a Prospective Trial , 2002, Journal of orthopaedic trauma.

[13]  D. Paley,et al.  Ilizarov bone transport treatment for tibial defects. , 2000, Journal of orthopaedic trauma.

[14]  G. Cierny,et al.  Infected tibial nonunions (1981-1995). The evolution of change. , 1999, Clinical orthopaedics and related research.

[15]  G. Walenkamp,et al.  Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. , 1998, Acta orthopaedica Scandinavica.

[16]  D. Haas,et al.  Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. , 1996, The American journal of medicine.

[17]  G. Dendrinos,et al.  Use of the Ilizarov technique for treatment of non-union of the tibia associated with infection. , 1995, The Journal of bone and joint surgery. American volume.

[18]  D. Paley,et al.  Variables affecting time to bone healing during limb lengthening. , 1994, Clinical orthopaedics and related research.

[19]  D. M. Anger,et al.  The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. , 1993, Clinical orthopaedics and related research.

[20]  J. Calhoun,et al.  Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. , 1993, Clinical orthopaedics and related research.

[21]  David M. Wall,et al.  Management of segmental defects by the Ilizarov intercalary bone transport method. , 1992, Clinical orthopaedics and related research.

[22]  D. Paley,et al.  Ilizarov treatment of tibial nonunions with bone loss. , 1989, Clinical orthopaedics and related research.

[23]  V. I. Braĭtsev [Anaerobic osteomyelitis]. , 1954, Khirurgiia.